Industry Welcomes Mandatory EU Joint Clinical Assessments For HTA
Draft proposals to improve EU-wide cooperation on health technology assessments, including mandatory joint clinical assessments, have won support from EFPIA, the European Federation of Pharmaceutical Industries and Associations.
You may also be interested in...
The European Parliament and EU Council have reached an agreement on taking forward proposals for greater cooperation on health technology assessments.
The umbrella organization for public insurers is also expected to publish its own suggestions on how to cut spending on pharmaceuticals, including interim prices for conditionally approved drugs.
The Alliance For Regenerative Medicines is calling for advanced therapies to be given greater priority where joint clinical assessments are concerned.